News & Announcements
Varian-Equipped Maryland Proton Treatment Center Completes First Patient Treatment
February 23, 2016
Varian Medical Systems (NYSE: VAR), today announced the Maryland Proton Treatment Center (MPTC) successfully completed its first patient treatment with the Varian ProBeam® system. The MPTC at the University of Maryland BioPark in West Baltimore houses five treatment rooms and is the first in the Eastern US to offer image-guided intensity-modulated proton therapy (IMPT) with a ProBeam system.
Proton therapy makes it possible to treat certain types of cancer more precisely and with potentially fewer side effects than is possible with conventional radiation therapy. With proton therapy, the risk of damage to healthy tissues and potential side effects are reduced because proton beams can be controlled so that they deposit their energy within the tumor site rather than passing all the way through the patient.